Sex, age, cardiovascular risk factors, and coronary heart disease: A prospective follow-up study of 14 786 middle-aged men and women in Finland

Circulation

Volumn 99, Issue 9, 1999, Pages 1165-1172

  Jousilahti, Pekka ^a   Vartiainen, Erkki ^a   Tuomilehto, Jaakko ^a   Puska, Pekka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Aging; Coronary disease; Epidemiology; Risk factors; Sex

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; FEMALE; FINLAND; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO; SMOKING;

EID: 0033537674     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.9.1165     Document Type: Article

References (47)

1. Castelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am J Med. 1984;76:4-12.
2. Thelle D. Women and coronary heart disease: a review with special emphasis on some risk factors. Lipid Rev. 1990;4:33-39.
3. Thom TJ, Epstein FH, Feldman JJ, Leaverton PE, Wolz M. Total Mortality and Mortality From Heart Disease, Cancer and Stroke From 1950 to 1987 in 27 Countries. Bethesda, Md: National Institutes of Health, 1992. NIH publication 92-3088.
4. Kuhn FE, Rackley CE. Coronary artery disease in women: risk factors, evaluation, treatment, and prevention. Arch Intern Med. 1993;153: 2626-2636.
5. WHO MONICA Project (prepared by Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas A-M, Pajak A). Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
6. Njolstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction: a 12-year follow-up of the Finnmark Study. Circulation. 1996;93:450-456.
7. Rich-Edwards JW, Manson JAE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med. 1995;332: 1758-1766.
8. Jackson R, Chambless L, Higgins M, Kuulasmaa K, Wijnberg L, Williams D (WHO MONICA Project, and ARIC Study). Sex difference in ischaemic heart disease mortality and risk factors in 46 communities: an ecologic analysis. Cardiovasc Risk Factors. 1997;7:43-54.
9. Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge, Mass, and London, UK: Harvard University Press; 1980.
10. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. Dallas, Tex: American Heart Association Monograph No. 60, 1978.
11. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease. Arch Intern Med. 1992;152: 56-64.
12. NIH Consensus Conference. Triglyceride, high-density lipoprotein and coronary heart disease. JAMA. 1993;269:505-510.
13. Corrao JM, Becker RC, Ockene IS, Hamilton GA. Coronary heart disease risk factors in women. Cardiology. 1990;77(suppl 2):8-24.
14. Jacobs DR Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1990;131:32-47.
15. Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, Monson RR, Stason W, Hennekens CH. Relative and absolute excess risk of coronary heart disease among women who smoke cigarettes. N Engl J Med. 1987;317:1303-1309.
16. Manson JE, Colditz GA, Stampfer MJ, Willet WC, Rosner B, Monson RR, Speizer FE, Hennekens CH. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990;322:882-889.
17. Head J, Fuller JH. International variations in mortality among diabetic patients: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 1990;33:477-481.
18. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality: 15-year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93:1372-1379.
19. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A. Twenty year trends in coronary risk factors in North Karelia and in other areas in Finland. Int J Epidemiol. 1994;23:495-503.
20. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol. 1988;41:105-114.
21. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34: 187-220.
22. SAS Institute, Inc. SAS/STAT User's Guide, Version 6. 4th ed, volume 1-2. Gary, NC: SAS Institute Inc: 1990.
23. Tuomilehto J, Tanskanen A, Salonen JT, Nissinen A, Koskela K. Effects of smoking and stopping smoking on serum high-density lipoprotein cholesterol levels in a representative population sample. Prev Med. 1986; 15:35-45.
24. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Twenty-year dynamics of serum cholesterol in middle-aged population of eastern Finland. Ann Intern Med. 1996;125:713-722.
25. National High Blood Pressure Education Program Working Group Report on Primary Prevention of Hypertension. Arch Intern Med. 1993;153: 186-208.
26. Jousilahti P, Tuomilehto J, Vartiainen E, Valle T, Nissinen A. Body mass index, blood pressure, diabetes, and the risk of anti-hypertensive drug treatment: 12-year follow-up of middle-aged people in eastern Finland. J Hum Hypertens. 1995;9:847-854.
27. Johnson A. Sex differentials in coronary heart disease: the explanatory role of primary risk factors. J Health Soc Behav. 1977;18:46-54.
28. Larsson B, Bengtsson C, Björntorp P, Lapidus L, Sjöström L, Svärdsudd K, Tibblin G, Wedel H, Welin L, Wilhelmsen L. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The Study of Men Born in 1913 and the Study of Women, Göteborg. Am J Epidemiol. 1992;135:266-273.
29. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989;321:641-646.
30. Bonithon-Kopp C, Scarabin P-Y, Darne B, Malmejak A, Guize L. Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int J Epidemiol. 1990;19:42-48.
31. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in post menopausal women. Ann Intern Med. 1992;117:1016-1037.
32. Shahar E, Folsom AR, Salomaa VV, Stinson VL, McGovern PG, Shimakawa T, Chambless LE, Wu KK, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Circulation. 1996;93:1970-1975.
33. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke and coronary heart disease, I: effects of prolonged differences in blood pressure: evidence from nine prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
34. Viikari J, Rönnemaa T. Seppänen A, Marniemi J, Porkka K, Räsänen L, Uhari M, Salo MK, Kaprio EA, Nuutinen EM, Pesonen E, Pietikäinen M, Dahl M, Åkerblom HK. Serum lipids and lipoproteins in children, adolescents and young adults in 1980-1986. Ann Med. 1991;23:53-59.
35. Jousilahti P, Puska P, Vartiainen E, Pekkanen J, Tuomilehto J. Parental history of premature coronary heart disease: an independent risk factor of myocardial infarction. J Clin Epidemiol. 1996;49:497-503.
36. Wood PD, Stefanick ML, Dreon DM, Frey-Hewitt B, Garay SC, Williams PT, Superko HR, Fortmann SP, Albers JJ, Vranizan KM, Albers JJ, Vranizan KM, Ellsworth NM, Terry RB, Haskell WL. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med. 1988;319:1173-1179.
37. Jousilahti P, Vartiainen E, Pekkanen J, Tuomilehto J, Sundval J, Puska P. Serum cholesterol distribution and coronary heart disease risk: observations and predictions among the middle-aged population in eastern Finland. Circulation. 1998;97:1087-1094.
38. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III: analysis of data from trials of salt reduction. BMJ. 1991;302:819-824.
39. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Goldwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease, II: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-838.
40. Staessen JA, Fagard R, Lutgarde T, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757-764.
41. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
42. Johannesson M, Jönsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. N Engl J Med. 1997;336:332-336.
43. Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension. 1989; 13(suppl I):I-2-I-12.
44. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
45. Belchetz PE. Hormonal treatment of postmenopausal women. N Engl J Med. 1994;330:1062-1071.
46. Bush TL, Barret-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality in non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-1109.
47. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up of the Nurses' Health Study. N Engl J Med. 1991;325:756-762.